… ProQR Announces Annual General Meeting of Shareholders and … & CAMBRIDGE, Mass., June 01, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a …
… ProQR Therapeutics to Host Virtual R&D Event on March 29, … (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through … under “Events” in the “Investors & Media” section of ProQR’s website at www.proqr.com/events . The archived …
… ProQR Supports Rare Disease Day 2018 and Honors Henri A. … the legacy of the late Henri A. Termeer, co-founder of ProQR, being held on the same day in Boston, MA. Henri … Genzyme and a visionary and pioneer for rare diseases, was ProQR’s co-founder in 2012 and vice chairman of the …
… ProQR Announces Closing of Underwritten Public Offering and … (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (“ProQR”), a company dedicated to changing lives through … and commissions and other offering expenses payable by ProQR. All of the shares in the Offering were sold by ProQR. …
LEIDEN, Netherlands & CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR) will host a Research & Development Day for investors on Tuesday, January 29 at 8:00 am ET at the Lotte New York Palace Hotel in New York, NY.